Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults

This multimodal approach is well tolerated, and quality of life remains preserved. The relatively long median survival time is promising but a further randomised double blind placebo controlled parallel designed clinical trial should be performed to confirm these results.